Global Plague Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Plague Therapeutics Industry Forecast” looks at past sales and reviews total world Plague Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Plague Therapeutics sales for 2023 through 2029. With Plague Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plague Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Plague Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plague Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plague Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plague Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plague Therapeutics.
The global Plague Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Plague Therapeutics players cover CordenPharma, Cipher Pharmaceuticals, Pfizer, Bayer HealthCare, Eli Lilly, Achaogen, Aurobindo Pharma, GlaxoSmithKline and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Plague Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Plague Therapeutics Industry Forecast” looks at past sales and reviews total world Plague Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Plague Therapeutics sales for 2023 through 2029. With Plague Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plague Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Plague Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plague Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plague Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plague Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plague Therapeutics.
The global Plague Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Plague Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Plague Therapeutics players cover CordenPharma, Cipher Pharmaceuticals, Pfizer, Bayer HealthCare, Eli Lilly, Achaogen, Aurobindo Pharma, GlaxoSmithKline and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Plague Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Vaccine
- Drugs
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CordenPharma
- Cipher Pharmaceuticals
- Pfizer
- Bayer HealthCare
- Eli Lilly
- Achaogen
- Aurobindo Pharma
- GlaxoSmithKline
- Bristol-Myers Squibb
- Aspen Pharmacare
- Biocon
- Astellas Pharma
- Melinta Therapeutics
- Basilea Pharmaceutica
- Allergan
- Abbott
- AstraZeneca
- AmpliPhi Biosciences
- Actelion Pharmaceuticals
- Chiesi Farmaceutici
- Exoxemis
- Merck
- DynPort Vaccine Company LLC
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plague Therapeutics Market Size 2018-2029
2.1.2 Plague Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Plague Therapeutics Segment by Type
2.2.1 Vaccine
2.2.2 Drugs
2.3 Plague Therapeutics Market Size by Type
2.3.1 Plague Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Plague Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Plague Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others
2.5 Plague Therapeutics Market Size by Application
2.5.1 Plague Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Plague Therapeutics Market Size Market Share by Application (2018-2023)
3 PLAGUE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Plague Therapeutics Market Size Market Share by Players
3.1.1 Global Plague Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Plague Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Plague Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PLAGUE THERAPEUTICS BY REGIONS
4.1 Plague Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Plague Therapeutics Market Size Growth (2018-2023)
4.3 APAC Plague Therapeutics Market Size Growth (2018-2023)
4.4 Europe Plague Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Plague Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Plague Therapeutics Market Size by Country (2018-2023)
5.2 Americas Plague Therapeutics Market Size by Type (2018-2023)
5.3 Americas Plague Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plague Therapeutics Market Size by Region (2018-2023)
6.2 APAC Plague Therapeutics Market Size by Type (2018-2023)
6.3 APAC Plague Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Plague Therapeutics by Country (2018-2023)
7.2 Europe Plague Therapeutics Market Size by Type (2018-2023)
7.3 Europe Plague Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plague Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Plague Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Plague Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PLAGUE THERAPEUTICS MARKET FORECAST
10.1 Global Plague Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Plague Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Plague Therapeutics Forecast
10.1.3 APAC Plague Therapeutics Forecast
10.1.4 Europe Plague Therapeutics Forecast
10.1.5 Middle East & Africa Plague Therapeutics Forecast
10.2 Americas Plague Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Plague Therapeutics Market Forecast
10.2.2 Canada Plague Therapeutics Market Forecast
10.2.3 Mexico Plague Therapeutics Market Forecast
10.2.4 Brazil Plague Therapeutics Market Forecast
10.3 APAC Plague Therapeutics Forecast by Region (2024-2029)
10.3.1 China Plague Therapeutics Market Forecast
10.3.2 Japan Plague Therapeutics Market Forecast
10.3.3 Korea Plague Therapeutics Market Forecast
10.3.4 Southeast Asia Plague Therapeutics Market Forecast
10.3.5 India Plague Therapeutics Market Forecast
10.3.6 Australia Plague Therapeutics Market Forecast
10.4 Europe Plague Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Plague Therapeutics Market Forecast
10.4.2 France Plague Therapeutics Market Forecast
10.4.3 UK Plague Therapeutics Market Forecast
10.4.4 Italy Plague Therapeutics Market Forecast
10.4.5 Russia Plague Therapeutics Market Forecast
10.5 Middle East & Africa Plague Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Plague Therapeutics Market Forecast
10.5.2 South Africa Plague Therapeutics Market Forecast
10.5.3 Israel Plague Therapeutics Market Forecast
10.5.4 Turkey Plague Therapeutics Market Forecast
10.5.5 GCC Countries Plague Therapeutics Market Forecast
10.6 Global Plague Therapeutics Forecast by Type (2024-2029)
10.7 Global Plague Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 CordenPharma
11.1.1 CordenPharma Company Information
11.1.2 CordenPharma Plague Therapeutics Product Offered
11.1.3 CordenPharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 CordenPharma Main Business Overview
11.1.5 CordenPharma Latest Developments
11.2 Cipher Pharmaceuticals
11.2.1 Cipher Pharmaceuticals Company Information
11.2.2 Cipher Pharmaceuticals Plague Therapeutics Product Offered
11.2.3 Cipher Pharmaceuticals Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cipher Pharmaceuticals Main Business Overview
11.2.5 Cipher Pharmaceuticals Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Plague Therapeutics Product Offered
11.3.3 Pfizer Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Information
11.4.2 Bayer HealthCare Plague Therapeutics Product Offered
11.4.3 Bayer HealthCare Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer HealthCare Main Business Overview
11.4.5 Bayer HealthCare Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Plague Therapeutics Product Offered
11.5.3 Eli Lilly Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Achaogen
11.6.1 Achaogen Company Information
11.6.2 Achaogen Plague Therapeutics Product Offered
11.6.3 Achaogen Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Achaogen Main Business Overview
11.6.5 Achaogen Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Plague Therapeutics Product Offered
11.7.3 Aurobindo Pharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Plague Therapeutics Product Offered
11.8.3 GlaxoSmithKline Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Plague Therapeutics Product Offered
11.9.3 Bristol-Myers Squibb Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Aspen Pharmacare
11.10.1 Aspen Pharmacare Company Information
11.10.2 Aspen Pharmacare Plague Therapeutics Product Offered
11.10.3 Aspen Pharmacare Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Aspen Pharmacare Main Business Overview
11.10.5 Aspen Pharmacare Latest Developments
11.11 Biocon
11.11.1 Biocon Company Information
11.11.2 Biocon Plague Therapeutics Product Offered
11.11.3 Biocon Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Biocon Main Business Overview
11.11.5 Biocon Latest Developments
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Information
11.12.2 Astellas Pharma Plague Therapeutics Product Offered
11.12.3 Astellas Pharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astellas Pharma Main Business Overview
11.12.5 Astellas Pharma Latest Developments
11.13 Melinta Therapeutics
11.13.1 Melinta Therapeutics Company Information
11.13.2 Melinta Therapeutics Plague Therapeutics Product Offered
11.13.3 Melinta Therapeutics Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Melinta Therapeutics Main Business Overview
11.13.5 Melinta Therapeutics Latest Developments
11.14 Basilea Pharmaceutica
11.14.1 Basilea Pharmaceutica Company Information
11.14.2 Basilea Pharmaceutica Plague Therapeutics Product Offered
11.14.3 Basilea Pharmaceutica Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Basilea Pharmaceutica Main Business Overview
11.14.5 Basilea Pharmaceutica Latest Developments
11.15 Allergan
11.15.1 Allergan Company Information
11.15.2 Allergan Plague Therapeutics Product Offered
11.15.3 Allergan Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Allergan Main Business Overview
11.15.5 Allergan Latest Developments
11.16 Abbott
11.16.1 Abbott Company Information
11.16.2 Abbott Plague Therapeutics Product Offered
11.16.3 Abbott Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Abbott Main Business Overview
11.16.5 Abbott Latest Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Company Information
11.17.2 AstraZeneca Plague Therapeutics Product Offered
11.17.3 AstraZeneca Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 AstraZeneca Main Business Overview
11.17.5 AstraZeneca Latest Developments
11.18 AmpliPhi Biosciences
11.18.1 AmpliPhi Biosciences Company Information
11.18.2 AmpliPhi Biosciences Plague Therapeutics Product Offered
11.18.3 AmpliPhi Biosciences Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 AmpliPhi Biosciences Main Business Overview
11.18.5 AmpliPhi Biosciences Latest Developments
11.19 Actelion Pharmaceuticals
11.19.1 Actelion Pharmaceuticals Company Information
11.19.2 Actelion Pharmaceuticals Plague Therapeutics Product Offered
11.19.3 Actelion Pharmaceuticals Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Actelion Pharmaceuticals Main Business Overview
11.19.5 Actelion Pharmaceuticals Latest Developments
11.20 Chiesi Farmaceutici
11.20.1 Chiesi Farmaceutici Company Information
11.20.2 Chiesi Farmaceutici Plague Therapeutics Product Offered
11.20.3 Chiesi Farmaceutici Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Chiesi Farmaceutici Main Business Overview
11.20.5 Chiesi Farmaceutici Latest Developments
11.21 Exoxemis
11.21.1 Exoxemis Company Information
11.21.2 Exoxemis Plague Therapeutics Product Offered
11.21.3 Exoxemis Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Exoxemis Main Business Overview
11.21.5 Exoxemis Latest Developments
11.22 Merck
11.22.1 Merck Company Information
11.22.2 Merck Plague Therapeutics Product Offered
11.22.3 Merck Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Merck Main Business Overview
11.22.5 Merck Latest Developments
11.23 DynPort Vaccine Company LLC
11.23.1 DynPort Vaccine Company LLC Company Information
11.23.2 DynPort Vaccine Company LLC Plague Therapeutics Product Offered
11.23.3 DynPort Vaccine Company LLC Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 DynPort Vaccine Company LLC Main Business Overview
11.23.5 DynPort Vaccine Company LLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Plague Therapeutics Market Size 2018-2029
2.1.2 Plague Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Plague Therapeutics Segment by Type
2.2.1 Vaccine
2.2.2 Drugs
2.3 Plague Therapeutics Market Size by Type
2.3.1 Plague Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Plague Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Plague Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others
2.5 Plague Therapeutics Market Size by Application
2.5.1 Plague Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Plague Therapeutics Market Size Market Share by Application (2018-2023)
3 PLAGUE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Plague Therapeutics Market Size Market Share by Players
3.1.1 Global Plague Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Plague Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Plague Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PLAGUE THERAPEUTICS BY REGIONS
4.1 Plague Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Plague Therapeutics Market Size Growth (2018-2023)
4.3 APAC Plague Therapeutics Market Size Growth (2018-2023)
4.4 Europe Plague Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Plague Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Plague Therapeutics Market Size by Country (2018-2023)
5.2 Americas Plague Therapeutics Market Size by Type (2018-2023)
5.3 Americas Plague Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plague Therapeutics Market Size by Region (2018-2023)
6.2 APAC Plague Therapeutics Market Size by Type (2018-2023)
6.3 APAC Plague Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Plague Therapeutics by Country (2018-2023)
7.2 Europe Plague Therapeutics Market Size by Type (2018-2023)
7.3 Europe Plague Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Plague Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Plague Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Plague Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PLAGUE THERAPEUTICS MARKET FORECAST
10.1 Global Plague Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Plague Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Plague Therapeutics Forecast
10.1.3 APAC Plague Therapeutics Forecast
10.1.4 Europe Plague Therapeutics Forecast
10.1.5 Middle East & Africa Plague Therapeutics Forecast
10.2 Americas Plague Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Plague Therapeutics Market Forecast
10.2.2 Canada Plague Therapeutics Market Forecast
10.2.3 Mexico Plague Therapeutics Market Forecast
10.2.4 Brazil Plague Therapeutics Market Forecast
10.3 APAC Plague Therapeutics Forecast by Region (2024-2029)
10.3.1 China Plague Therapeutics Market Forecast
10.3.2 Japan Plague Therapeutics Market Forecast
10.3.3 Korea Plague Therapeutics Market Forecast
10.3.4 Southeast Asia Plague Therapeutics Market Forecast
10.3.5 India Plague Therapeutics Market Forecast
10.3.6 Australia Plague Therapeutics Market Forecast
10.4 Europe Plague Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Plague Therapeutics Market Forecast
10.4.2 France Plague Therapeutics Market Forecast
10.4.3 UK Plague Therapeutics Market Forecast
10.4.4 Italy Plague Therapeutics Market Forecast
10.4.5 Russia Plague Therapeutics Market Forecast
10.5 Middle East & Africa Plague Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Plague Therapeutics Market Forecast
10.5.2 South Africa Plague Therapeutics Market Forecast
10.5.3 Israel Plague Therapeutics Market Forecast
10.5.4 Turkey Plague Therapeutics Market Forecast
10.5.5 GCC Countries Plague Therapeutics Market Forecast
10.6 Global Plague Therapeutics Forecast by Type (2024-2029)
10.7 Global Plague Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 CordenPharma
11.1.1 CordenPharma Company Information
11.1.2 CordenPharma Plague Therapeutics Product Offered
11.1.3 CordenPharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 CordenPharma Main Business Overview
11.1.5 CordenPharma Latest Developments
11.2 Cipher Pharmaceuticals
11.2.1 Cipher Pharmaceuticals Company Information
11.2.2 Cipher Pharmaceuticals Plague Therapeutics Product Offered
11.2.3 Cipher Pharmaceuticals Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cipher Pharmaceuticals Main Business Overview
11.2.5 Cipher Pharmaceuticals Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Plague Therapeutics Product Offered
11.3.3 Pfizer Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Information
11.4.2 Bayer HealthCare Plague Therapeutics Product Offered
11.4.3 Bayer HealthCare Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer HealthCare Main Business Overview
11.4.5 Bayer HealthCare Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Plague Therapeutics Product Offered
11.5.3 Eli Lilly Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Achaogen
11.6.1 Achaogen Company Information
11.6.2 Achaogen Plague Therapeutics Product Offered
11.6.3 Achaogen Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Achaogen Main Business Overview
11.6.5 Achaogen Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Plague Therapeutics Product Offered
11.7.3 Aurobindo Pharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Plague Therapeutics Product Offered
11.8.3 GlaxoSmithKline Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Plague Therapeutics Product Offered
11.9.3 Bristol-Myers Squibb Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Aspen Pharmacare
11.10.1 Aspen Pharmacare Company Information
11.10.2 Aspen Pharmacare Plague Therapeutics Product Offered
11.10.3 Aspen Pharmacare Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Aspen Pharmacare Main Business Overview
11.10.5 Aspen Pharmacare Latest Developments
11.11 Biocon
11.11.1 Biocon Company Information
11.11.2 Biocon Plague Therapeutics Product Offered
11.11.3 Biocon Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Biocon Main Business Overview
11.11.5 Biocon Latest Developments
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Information
11.12.2 Astellas Pharma Plague Therapeutics Product Offered
11.12.3 Astellas Pharma Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astellas Pharma Main Business Overview
11.12.5 Astellas Pharma Latest Developments
11.13 Melinta Therapeutics
11.13.1 Melinta Therapeutics Company Information
11.13.2 Melinta Therapeutics Plague Therapeutics Product Offered
11.13.3 Melinta Therapeutics Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Melinta Therapeutics Main Business Overview
11.13.5 Melinta Therapeutics Latest Developments
11.14 Basilea Pharmaceutica
11.14.1 Basilea Pharmaceutica Company Information
11.14.2 Basilea Pharmaceutica Plague Therapeutics Product Offered
11.14.3 Basilea Pharmaceutica Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Basilea Pharmaceutica Main Business Overview
11.14.5 Basilea Pharmaceutica Latest Developments
11.15 Allergan
11.15.1 Allergan Company Information
11.15.2 Allergan Plague Therapeutics Product Offered
11.15.3 Allergan Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Allergan Main Business Overview
11.15.5 Allergan Latest Developments
11.16 Abbott
11.16.1 Abbott Company Information
11.16.2 Abbott Plague Therapeutics Product Offered
11.16.3 Abbott Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Abbott Main Business Overview
11.16.5 Abbott Latest Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Company Information
11.17.2 AstraZeneca Plague Therapeutics Product Offered
11.17.3 AstraZeneca Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 AstraZeneca Main Business Overview
11.17.5 AstraZeneca Latest Developments
11.18 AmpliPhi Biosciences
11.18.1 AmpliPhi Biosciences Company Information
11.18.2 AmpliPhi Biosciences Plague Therapeutics Product Offered
11.18.3 AmpliPhi Biosciences Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 AmpliPhi Biosciences Main Business Overview
11.18.5 AmpliPhi Biosciences Latest Developments
11.19 Actelion Pharmaceuticals
11.19.1 Actelion Pharmaceuticals Company Information
11.19.2 Actelion Pharmaceuticals Plague Therapeutics Product Offered
11.19.3 Actelion Pharmaceuticals Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Actelion Pharmaceuticals Main Business Overview
11.19.5 Actelion Pharmaceuticals Latest Developments
11.20 Chiesi Farmaceutici
11.20.1 Chiesi Farmaceutici Company Information
11.20.2 Chiesi Farmaceutici Plague Therapeutics Product Offered
11.20.3 Chiesi Farmaceutici Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Chiesi Farmaceutici Main Business Overview
11.20.5 Chiesi Farmaceutici Latest Developments
11.21 Exoxemis
11.21.1 Exoxemis Company Information
11.21.2 Exoxemis Plague Therapeutics Product Offered
11.21.3 Exoxemis Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Exoxemis Main Business Overview
11.21.5 Exoxemis Latest Developments
11.22 Merck
11.22.1 Merck Company Information
11.22.2 Merck Plague Therapeutics Product Offered
11.22.3 Merck Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Merck Main Business Overview
11.22.5 Merck Latest Developments
11.23 DynPort Vaccine Company LLC
11.23.1 DynPort Vaccine Company LLC Company Information
11.23.2 DynPort Vaccine Company LLC Plague Therapeutics Product Offered
11.23.3 DynPort Vaccine Company LLC Plague Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 DynPort Vaccine Company LLC Main Business Overview
11.23.5 DynPort Vaccine Company LLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Plague Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Vaccine
Table 3. Major Players of Drugs
Table 4. Plague Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 7. Plague Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 10. Global Plague Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Plague Therapeutics Revenue Market Share by Player (2018-2023)
Table 12. Plague Therapeutics Key Players Head office and Products Offered
Table 13. Plague Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plague Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Plague Therapeutics Market Size Market Share by Regions (2018-2023)
Table 18. Global Plague Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Plague Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Plague Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Plague Therapeutics Market Size Market Share by Country (2018-2023)
Table 22. Americas Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 24. Americas Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 26. APAC Plague Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Plague Therapeutics Market Size Market Share by Region (2018-2023)
Table 28. APAC Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 30. APAC Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 32. Europe Plague Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Plague Therapeutics Market Size Market Share by Country (2018-2023)
Table 34. Europe Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 36. Europe Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Plague Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Plague Therapeutics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Plague Therapeutics
Table 45. Key Market Challenges & Risks of Plague Therapeutics
Table 46. Key Industry Trends of Plague Therapeutics
Table 47. Global Plague Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Plague Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Plague Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Plague Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. CordenPharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 52. CordenPharma Plague Therapeutics Product Offered
Table 53. CordenPharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. CordenPharma Main Business
Table 55. CordenPharma Latest Developments
Table 56. Cipher Pharmaceuticals Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 57. Cipher Pharmaceuticals Plague Therapeutics Product Offered
Table 58. Cipher Pharmaceuticals Main Business
Table 59. Cipher Pharmaceuticals Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cipher Pharmaceuticals Latest Developments
Table 61. Pfizer Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 62. Pfizer Plague Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Latest Developments
Table 66. Bayer HealthCare Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 67. Bayer HealthCare Plague Therapeutics Product Offered
Table 68. Bayer HealthCare Main Business
Table 69. Bayer HealthCare Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bayer HealthCare Latest Developments
Table 71. Eli Lilly Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 72. Eli Lilly Plague Therapeutics Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Eli Lilly Latest Developments
Table 76. Achaogen Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 77. Achaogen Plague Therapeutics Product Offered
Table 78. Achaogen Main Business
Table 79. Achaogen Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Achaogen Latest Developments
Table 81. Aurobindo Pharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 82. Aurobindo Pharma Plague Therapeutics Product Offered
Table 83. Aurobindo Pharma Main Business
Table 84. Aurobindo Pharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Aurobindo Pharma Latest Developments
Table 86. GlaxoSmithKline Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 87. GlaxoSmithKline Plague Therapeutics Product Offered
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. GlaxoSmithKline Latest Developments
Table 91. Bristol-Myers Squibb Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 92. Bristol-Myers Squibb Plague Therapeutics Product Offered
Table 93. Bristol-Myers Squibb Main Business
Table 94. Bristol-Myers Squibb Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Latest Developments
Table 96. Aspen Pharmacare Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 97. Aspen Pharmacare Plague Therapeutics Product Offered
Table 98. Aspen Pharmacare Main Business
Table 99. Aspen Pharmacare Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Aspen Pharmacare Latest Developments
Table 101. Biocon Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 102. Biocon Plague Therapeutics Product Offered
Table 103. Biocon Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Biocon Main Business
Table 105. Biocon Latest Developments
Table 106. Astellas Pharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 107. Astellas Pharma Plague Therapeutics Product Offered
Table 108. Astellas Pharma Main Business
Table 109. Astellas Pharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Astellas Pharma Latest Developments
Table 111. Melinta Therapeutics Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 112. Melinta Therapeutics Plague Therapeutics Product Offered
Table 113. Melinta Therapeutics Main Business
Table 114. Melinta Therapeutics Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Melinta Therapeutics Latest Developments
Table 116. Basilea Pharmaceutica Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 117. Basilea Pharmaceutica Plague Therapeutics Product Offered
Table 118. Basilea Pharmaceutica Main Business
Table 119. Basilea Pharmaceutica Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Basilea Pharmaceutica Latest Developments
Table 121. Allergan Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 122. Allergan Plague Therapeutics Product Offered
Table 123. Allergan Main Business
Table 124. Allergan Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Allergan Latest Developments
Table 126. Abbott Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 127. Abbott Plague Therapeutics Product Offered
Table 128. Abbott Main Business
Table 129. Abbott Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Abbott Latest Developments
Table 131. AstraZeneca Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 132. AstraZeneca Plague Therapeutics Product Offered
Table 133. AstraZeneca Main Business
Table 134. AstraZeneca Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. AstraZeneca Latest Developments
Table 136. AmpliPhi Biosciences Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 137. AmpliPhi Biosciences Plague Therapeutics Product Offered
Table 138. AmpliPhi Biosciences Main Business
Table 139. AmpliPhi Biosciences Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. AmpliPhi Biosciences Latest Developments
Table 141. Actelion Pharmaceuticals Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 142. Actelion Pharmaceuticals Plague Therapeutics Product Offered
Table 143. Actelion Pharmaceuticals Main Business
Table 144. Actelion Pharmaceuticals Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Actelion Pharmaceuticals Latest Developments
Table 146. Chiesi Farmaceutici Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 147. Chiesi Farmaceutici Plague Therapeutics Product Offered
Table 148. Chiesi Farmaceutici Main Business
Table 149. Chiesi Farmaceutici Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Chiesi Farmaceutici Latest Developments
Table 151. Exoxemis Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 152. Exoxemis Plague Therapeutics Product Offered
Table 153. Exoxemis Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Exoxemis Main Business
Table 155. Exoxemis Latest Developments
Table 156. Merck Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 157. Merck Plague Therapeutics Product Offered
Table 158. Merck Main Business
Table 159. Merck Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Merck Latest Developments
Table 161. DynPort Vaccine Company LLC Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 162. DynPort Vaccine Company LLC Plague Therapeutics Product Offered
Table 163. DynPort Vaccine Company LLC Main Business
Table 164. DynPort Vaccine Company LLC Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. DynPort Vaccine Company LLC Latest Developments
Table 1. Plague Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Vaccine
Table 3. Major Players of Drugs
Table 4. Plague Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 7. Plague Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 10. Global Plague Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Plague Therapeutics Revenue Market Share by Player (2018-2023)
Table 12. Plague Therapeutics Key Players Head office and Products Offered
Table 13. Plague Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plague Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Plague Therapeutics Market Size Market Share by Regions (2018-2023)
Table 18. Global Plague Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Plague Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Plague Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Plague Therapeutics Market Size Market Share by Country (2018-2023)
Table 22. Americas Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 24. Americas Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 26. APAC Plague Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Plague Therapeutics Market Size Market Share by Region (2018-2023)
Table 28. APAC Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 30. APAC Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 32. Europe Plague Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Plague Therapeutics Market Size Market Share by Country (2018-2023)
Table 34. Europe Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 36. Europe Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Plague Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Plague Therapeutics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Plague Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Plague Therapeutics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Plague Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Plague Therapeutics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Plague Therapeutics
Table 45. Key Market Challenges & Risks of Plague Therapeutics
Table 46. Key Industry Trends of Plague Therapeutics
Table 47. Global Plague Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Plague Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Plague Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Plague Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. CordenPharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 52. CordenPharma Plague Therapeutics Product Offered
Table 53. CordenPharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. CordenPharma Main Business
Table 55. CordenPharma Latest Developments
Table 56. Cipher Pharmaceuticals Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 57. Cipher Pharmaceuticals Plague Therapeutics Product Offered
Table 58. Cipher Pharmaceuticals Main Business
Table 59. Cipher Pharmaceuticals Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cipher Pharmaceuticals Latest Developments
Table 61. Pfizer Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 62. Pfizer Plague Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Latest Developments
Table 66. Bayer HealthCare Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 67. Bayer HealthCare Plague Therapeutics Product Offered
Table 68. Bayer HealthCare Main Business
Table 69. Bayer HealthCare Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bayer HealthCare Latest Developments
Table 71. Eli Lilly Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 72. Eli Lilly Plague Therapeutics Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Eli Lilly Latest Developments
Table 76. Achaogen Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 77. Achaogen Plague Therapeutics Product Offered
Table 78. Achaogen Main Business
Table 79. Achaogen Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Achaogen Latest Developments
Table 81. Aurobindo Pharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 82. Aurobindo Pharma Plague Therapeutics Product Offered
Table 83. Aurobindo Pharma Main Business
Table 84. Aurobindo Pharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Aurobindo Pharma Latest Developments
Table 86. GlaxoSmithKline Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 87. GlaxoSmithKline Plague Therapeutics Product Offered
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. GlaxoSmithKline Latest Developments
Table 91. Bristol-Myers Squibb Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 92. Bristol-Myers Squibb Plague Therapeutics Product Offered
Table 93. Bristol-Myers Squibb Main Business
Table 94. Bristol-Myers Squibb Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Latest Developments
Table 96. Aspen Pharmacare Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 97. Aspen Pharmacare Plague Therapeutics Product Offered
Table 98. Aspen Pharmacare Main Business
Table 99. Aspen Pharmacare Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Aspen Pharmacare Latest Developments
Table 101. Biocon Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 102. Biocon Plague Therapeutics Product Offered
Table 103. Biocon Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Biocon Main Business
Table 105. Biocon Latest Developments
Table 106. Astellas Pharma Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 107. Astellas Pharma Plague Therapeutics Product Offered
Table 108. Astellas Pharma Main Business
Table 109. Astellas Pharma Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Astellas Pharma Latest Developments
Table 111. Melinta Therapeutics Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 112. Melinta Therapeutics Plague Therapeutics Product Offered
Table 113. Melinta Therapeutics Main Business
Table 114. Melinta Therapeutics Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Melinta Therapeutics Latest Developments
Table 116. Basilea Pharmaceutica Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 117. Basilea Pharmaceutica Plague Therapeutics Product Offered
Table 118. Basilea Pharmaceutica Main Business
Table 119. Basilea Pharmaceutica Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Basilea Pharmaceutica Latest Developments
Table 121. Allergan Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 122. Allergan Plague Therapeutics Product Offered
Table 123. Allergan Main Business
Table 124. Allergan Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Allergan Latest Developments
Table 126. Abbott Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 127. Abbott Plague Therapeutics Product Offered
Table 128. Abbott Main Business
Table 129. Abbott Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Abbott Latest Developments
Table 131. AstraZeneca Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 132. AstraZeneca Plague Therapeutics Product Offered
Table 133. AstraZeneca Main Business
Table 134. AstraZeneca Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. AstraZeneca Latest Developments
Table 136. AmpliPhi Biosciences Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 137. AmpliPhi Biosciences Plague Therapeutics Product Offered
Table 138. AmpliPhi Biosciences Main Business
Table 139. AmpliPhi Biosciences Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. AmpliPhi Biosciences Latest Developments
Table 141. Actelion Pharmaceuticals Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 142. Actelion Pharmaceuticals Plague Therapeutics Product Offered
Table 143. Actelion Pharmaceuticals Main Business
Table 144. Actelion Pharmaceuticals Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Actelion Pharmaceuticals Latest Developments
Table 146. Chiesi Farmaceutici Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 147. Chiesi Farmaceutici Plague Therapeutics Product Offered
Table 148. Chiesi Farmaceutici Main Business
Table 149. Chiesi Farmaceutici Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Chiesi Farmaceutici Latest Developments
Table 151. Exoxemis Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 152. Exoxemis Plague Therapeutics Product Offered
Table 153. Exoxemis Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Exoxemis Main Business
Table 155. Exoxemis Latest Developments
Table 156. Merck Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 157. Merck Plague Therapeutics Product Offered
Table 158. Merck Main Business
Table 159. Merck Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Merck Latest Developments
Table 161. DynPort Vaccine Company LLC Details, Company Type, Plague Therapeutics Area Served and Its Competitors
Table 162. DynPort Vaccine Company LLC Plague Therapeutics Product Offered
Table 163. DynPort Vaccine Company LLC Main Business
Table 164. DynPort Vaccine Company LLC Plague Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. DynPort Vaccine Company LLC Latest Developments
LIST OF FIGURES
Figure 1. Plague Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plague Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Plague Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Plague Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Plague Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Plague Therapeutics Market Size Market Share by Type in 2022
Figure 10. Plague Therapeutics in Hospital Pharmacies
Figure 11. Global Plague Therapeutics Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Plague Therapeutics in Retail Pharmacies
Figure 13. Global Plague Therapeutics Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Plague Therapeutics in Others
Figure 15. Global Plague Therapeutics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Plague Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Plague Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Plague Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Plague Therapeutics Value Market Share by Country in 2022
Figure 24. United States Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Plague Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Plague Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Plague Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Plague Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Plague Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Plague Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Plague Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Plague Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Plague Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Plague Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Plague Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Plague Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plague Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Plague Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Plague Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Plague Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Plague Therapeutics Market Size Market Share by Type in 2022
Figure 10. Plague Therapeutics in Hospital Pharmacies
Figure 11. Global Plague Therapeutics Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Plague Therapeutics in Retail Pharmacies
Figure 13. Global Plague Therapeutics Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Plague Therapeutics in Others
Figure 15. Global Plague Therapeutics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Plague Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Plague Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Plague Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Plague Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Plague Therapeutics Value Market Share by Country in 2022
Figure 24. United States Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Plague Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Plague Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Plague Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Plague Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Plague Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Plague Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Plague Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Plague Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Plague Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Plague Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Plague Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Plague Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Plague Therapeutics Market Size Market Share Forecast by Application (2024-2029)
